Amerikanische Gesellschaft für Hirudotherapie

Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations

Research article published in Journal of pharmaceutical and biomedical analysis (2012)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportArzneimittelentwicklungVolpi N et al. · Journal of pharmaceutical and biomedical analysis, 2012

Abstract

The adulteration of raw heparin (Hep) with a synthetic oversulfated chondroitin sulfate (OSCS) not found in nature produced in 2007-2008 a global crisis giving rise to the development of additional, new and specific methods for its quality assurance and purity. In this study, a simple and sensitive agarose-gel electrophoresis method has been developed for the visualization of OSCS in Hep samples along with other natural glycosaminoglycans possibly present as "process-related impurities", in particular dermatan sulfate (DS) and chondroitin sulfate (CS). Agarose-gel electrophoresis under non-conventional conditions is able to separate OSCS from Hep with its two components, the slow-moving and fast-moving species, DS and CS by performing separation for 15 h (overnight) and under high voltage (100 mA, ∼200 V). Densitometric scanning enabled us to calculate a limit of detection of ∼0.5 μg OSCS with a linear behaviour from 0.1 to 5 μg, comparable to CS/DS. Contaminated samples from Hep manufacturers were analyzed and quantitative data were found comparable to previous studies. Due to its capacity to process many samples in a single run and to the equipment commonly available in laboratories, this analytical method would be suitable for the identification and quantification of contamination by other polysaccharides, in particular OSCS and DS, within Hep preparations and formulations.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsChemistry, PharmaceuticalElectrophoresis, Agar GelHeparinQuality Control

Zusammenfassung

The adulteration of raw heparin (Hep) with a synthetic oversulfated chondroitin sulfate (OSCS) not found in nature produced in 2007-2008 a global crisis giving rise to the development of additional, new and specific methods for its quality assurance and purity.

Warum dies für die Hirudotherapie relevant ist

This study developed an agarose-gel electrophoresis method to detect oversulfated chondroitin sulfate (OSCS) and other natural glycosaminoglycans such as dermatan sulfate and chondroitin sulfate as impurities within heparin formulations following the 2007-2008 heparin crisis. The technique provides a sensitive, accessible way to identify and quantify polysaccharide contamination in heparin preparations and formulations. The abstract does not mention leeches, hirudotherapy, hirudin, or any leech-derived products, and makes no comparison between heparin and leech-based anticoagulants. Consequently, there is no direct relevance to the ASH domain; the work is strictly focused on pharmaceutical quality control of heparin.

Zitation

Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations

Volpi N et al. · Journal of pharmaceutical and biomedical analysis, 2012

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.